{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T17:22:19Z","timestamp":1791134539071,"version":"4.1.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Sleep Medicine"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.sleep.2012.07.008","type":"journal-article","created":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T21:30:56Z","timestamp":1349127056000},"page":"30-36","source":"Crossref","is-referenced-by-count":75,"title":["Mazindol in narcolepsy and idiopathic and symptomatic hypersomnia refractory to stimulants: A long-term chart review"],"prefix":"10.1016","volume":"14","author":[{"given":"Nandini","family":"Nittur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Konofal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Dauvilliers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Franco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smaranda","family":"Leu-Semenescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie Cochen De","family":"Cock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara O.","family":"Inocente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Bayard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Scholtz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Lecendreux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Arnulf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.sleep.2012.07.008_b0005","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1111\/j.1468-1331.2006.01473.x","article-title":"EFNS guidelines on management of narcolepsy","volume":"13","author":"Billiard","year":"2006","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.sleep.2012.07.008_b0010","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1093\/sleep\/30.12.1705","article-title":"Practice parameters for the treatment of narcolepsy and other hypersomnias of central origin","volume":"30","author":"Morgenthaler","year":"2007","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2012.07.008_b0015","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.nbd.2007.12.003","article-title":"An inverse agonist of the histamine H(3) receptor improves wakefulness in narcolepsy: studies in orexin\u2212\/\u2212mice and patients","volume":"30","author":"Lin","year":"2008","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.sleep.2012.07.008_b0020","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.sleep.2011.03.010","article-title":"Benefit and risk of modafinil in idiopathic hypersomnia vs. narcolepsy with cataplexy","volume":"12","author":"Lavault","year":"2011","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2012.07.008_b0025","first-page":"25","article-title":"Chemistry and pharmacology of mazindol","volume":"15","author":"Gogerty","year":"1976","journal-title":"Triangle"},{"key":"10.1016\/j.sleep.2012.07.008_b0030","first-page":"358","article-title":"Double-blind clinical evaluation of mazindol, dextroamphetamine, and placebo in treatment of exogenous obesity","volume":"15","author":"Defelice","year":"1973","journal-title":"Curr Ther Res Clin Exp"},{"key":"10.1016\/j.sleep.2012.07.008_b0035","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1021\/jm00236a014","article-title":"5-Aryl-2,3-dihydro-5H-imidazo [2,1-a]isoindol-5-ols. A novel class of anorectic agents","volume":"18","author":"Aeberli","year":"1975","journal-title":"J Med Chem"},{"key":"10.1016\/j.sleep.2012.07.008_b0040","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1177\/000992287301200308","article-title":"Clinical evaluation of the anorexic activity and safety of 42\u2013548 in children","volume":"12","author":"Sharma","year":"1973","journal-title":"Clin Pediatr"},{"key":"10.1016\/j.sleep.2012.07.008_b0045","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1185\/03007997509113660","article-title":"A multi-centre trial of mazindol (\u2018Teronac\u2019) in general practice in Ireland","volume":"3","author":"Evans","year":"1975","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.sleep.2012.07.008_b0050","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1600-0404.1979.tb02976.x","article-title":"Mazindol in the treatment of narcolepsy","volume":"60","author":"Parkes","year":"1979","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.sleep.2012.07.008_b0055","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1136\/bmj.290.6476.1167","article-title":"Amphetamine, mazindol, and fencamfamin in narcolepsy","volume":"290","author":"Shindler","year":"1985","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1016\/j.sleep.2012.07.008_b0060","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/sleep\/9.1.265","article-title":"Therapeutic effects of mazindol on narcolepsy","volume":"9","author":"Iijima","year":"1986","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2012.07.008_b0065","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0370-4475(86)80059-4","article-title":"Value of mazindol in Gelineau\u2019s disease. A propos of 10 cases","volume":"16","author":"Vespignani","year":"1986","journal-title":"Rev Electroencephalogr Neurophysiol Clin"},{"key":"10.1016\/j.sleep.2012.07.008_b0070","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1183\/09031936.00086308","article-title":"Fenfluramine-like cardiovascular side-effects of benfluorex","volume":"33","author":"Boutet","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1016\/j.sleep.2012.07.008_b0120","doi-asserted-by":"crossref","first-page":"e10128","DOI":"10.1371\/journal.pone.0010128","article-title":"Benfluorex and unexplained valvular heart disease: a case\u2013control study","volume":"5","author":"Frachon","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.sleep.2012.07.008_b0080","unstructured":"American Academy of Sleep Medicine. The international classification of sleep disorders \u2013 revised. In: Hauri P, editor. Chicago, IL: American Academy of Sleep Medicine; 2005."},{"key":"10.1016\/j.sleep.2012.07.008_b0085","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0140-6736(79)92495-4","article-title":"Clomipramine and clonazepam in narcolepsy","volume":"2","author":"Parkes","year":"1979","journal-title":"Lancet"},{"key":"10.1016\/j.sleep.2012.07.008_b0090","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1177\/030006057600400504","article-title":"Short-term and long-term clinical evaluation of a non-amphetaminic anorexiant (mazindol) in the treatment of obesity","volume":"4","author":"Enzi","year":"1976","journal-title":"J Int Med Res"},{"issue":"Suppl.","key":"10.1016\/j.sleep.2012.07.008_b0095","doi-asserted-by":"crossref","first-page":"549S","DOI":"10.1002\/j.1550-8528.1995.tb00226.x","article-title":"Clinical studies with mazindol","volume":"3","author":"Inoue","year":"1995","journal-title":"Obes Res"},{"key":"10.1016\/j.sleep.2012.07.008_b0100","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1080\/00926239508404398","article-title":"Antidepressant-induced orgasm disorder","volume":"21","author":"Segraves","year":"1995","journal-title":"J Sex Marital Ther"},{"key":"10.1016\/j.sleep.2012.07.008_b0105","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1177\/030006057400200505","article-title":"Mazindol in obesity with known cardiac disease: a clinical evaluation","volume":"2","author":"Bradley","year":"1974","journal-title":"J Int Med Res"},{"key":"10.1016\/j.sleep.2012.07.008_b0110","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1253\/jcj.64.218","article-title":"Delayed onset of pulmonary hypertension associated with an appetite suppressant, mazindol","volume":"64","author":"Hagiwara","year":"2000","journal-title":"Jpn Circ J"},{"key":"10.1016\/j.sleep.2012.07.008_b0115","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1161\/CIRCULATIONAHA.107.189473","volume":"117","author":"Vetter","year":"2008","journal-title":"Circulation"}],"container-title":["Sleep Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1389945712003115?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1389945712003115?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,20]],"date-time":"2018-11-20T11:51:50Z","timestamp":1542714710000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1389945712003115"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S1389945712003115"],"URL":"https:\/\/doi.org\/10.1016\/j.sleep.2012.07.008","relation":{},"ISSN":["1389-9457"],"issn-type":[{"value":"1389-9457","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}